Jump to content

Draft:Shao Li

From Wikipedia, the free encyclopedia
  • Comment: You don't invent notability by making small changes. His does not pass the bar. End of story for some years. Ldm1954 (talk) 23:39, 8 November 2023 (UTC)
  • Comment: Please read carefully WP:NACADEMIC. Nothing currently here demonstrates notability. A major cleanup is needed. Ldm1954 (talk) 13:48, 5 November 2023 (UTC)


In this Chinese name, the family name is Li.

Shao Li (Chinese: 李梢) is a tenured professor at Tsinghua University [1]. Li was elected as a member of the European Academy of Sciences and Arts[2], a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Biology, UK[3][4]. Li obtained his B.Sc from Beijing University of Chinese Medicine in 1995, M.S from Wannan College of Medicine in 1998 and M.D. from Beijing University of Chinese Medicine in 2001. He wrote the Network Pharmacology International Guideline in 2021[5] and was the editor of the network pharmacology monograph (Springer Press) in 2021[6]. His main research interest is in bioinformatics, network pharmacology and precision medicine on cancer prevention. He proposed the theory and technologies of "network target"[7] and natural medicine network pharmacology (ESI highly cited paper)[8].

Academic memberships[edit]

Li is currently serving as the director of the first Tsinghua University Interdisciplinary Institute of Traditional Chinese Medicine [9], and the Chairman of the Specialty Committee of Network Pharmacology of the World Federation of Chinese Medicine Society and Specialty Committee of Biomedical Big Data of the Chinese Society of Biotechnology. He also serves as Editorial Board Members including Cancer Biology & Medicine[10], Pharmacological Research[11], Journal of Ethnopharmacology. He has been invited to the NIH/NCI and other international conferences to deliver keynote speeches[12].

Honors and awards[edit]

He was elected World's Top 2% Scientists in 2019/2020/2021/2022/2023 (by Stanford University) [13]. He won the top award of both Gold Medal with congratulations of the Jury and Gold Medal in the 49th Geneva International Exhibition of Inventions (2024)[14][15]. He obtained the 1st Class of International Award for Outstanding Contribution to Chinese Medicine in 2020,[16] and the Li Shizhen Pharmaceutical Innovation Award in 2019. He was also awarded Grand Challenges 2015—Young Scientists (Bill & Melinda Gates Foundation, 2015), the National Outstanding Young Scientist (2012), network pharmacology patent (USA, 2012)[17], and National Science and Technology Progress Award (China, 2004).

External links[edit]

Shao Li-Tsinghua University Institute of TCM-X,Beijing

References[edit]

  1. ^ Tsinghua University. "Tsinghua University-Shao Li". www.au.tsinghua.edu.cn. Retrieved 2023-11-08.
  2. ^ "News | European Academy of Sciences and Arts". euro-acad.eu. Retrieved 2024-06-27.
  3. ^ Department of Automation. "Professor Li Shao elected as Fellow of the Royal Society of Biology". www.tsinghua.edu.cn. Retrieved 2023-05-17.
  4. ^ Tsinghua News Network. "Professor Li Shao elected as Fellow of the Royal Society of Chemistry". www.au.tsinghua.edu.cn. Retrieved 2023-05-17.
  5. ^ Li, Shao (2021-01-01). "Network Pharmacology Evaluation Method Guidance - Draft". World Journal of Traditional Chinese Medicine. 7 (1): 146. doi:10.4103/wjtcm.wjtcm_11_21. ISSN 2311-8571. S2CID 232328891.
  6. ^ Li, Shao, ed. (2021). Network Pharmacology. doi:10.1007/978-981-16-0753-0. ISBN 978-981-16-0752-3. S2CID 78332992.
  7. ^ S, Li (2015). "Mapping ancient remedies: Applying a network approach to traditional Chinese medicine". Science. 350 (6262): S72–S74.
  8. ^ Li, Shao; Zhang, Bo (2013-03-01). "Traditional Chinese medicine network pharmacology: theory, methodology and application". Chinese Journal of Natural Medicines. 11 (2): 110–120. doi:10.1016/S1875-5364(13)60037-0. ISSN 1875-5364. PMID 23787177. S2CID 1252771.
  9. ^ "Tsinghua University Institute of TCM-X,Beijing". tcmx.tsinghua.edu.cn (in Chinese (China)). Retrieved 2023-11-08.
  10. ^ "Editorial Board | Cancer Biology & Medicine". www.cancerbiomed.org. Retrieved 2023-11-07.
  11. ^ "Editorial board - Pharmacological Research | ScienceDirect.com by Elsevier". www.sciencedirect.com. Retrieved 2023-11-07.
  12. ^ "State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research—NCI Strategic Workshop Highlights of Discussion Report". academic.oup.com. Retrieved 2023-11-07.
  13. ^ Baas, Jeroen; Boyack, Kevin; Ioannidis, John P. A. (2021-10-19). "August 2021 data-update for "Updated science-wide author databases of standardized citation indicators"". 3. Elsevier BV. doi:10.17632/btchxktzyw.3. {{cite journal}}: Cite journal requires |journal= (help)
  14. ^ "Salon international des inventions de Genève", Wikipédia (in French), 2023-06-18, retrieved 2024-06-27
  15. ^ ""Chinese Medicine +AI" Tsinghua University Li Shao team won the highest award at the Geneva International Invention Exhibition". www.tsinghua.edu.cn. Retrieved 2024-06-27.
  16. ^ "International Award for Outstanding Contribution to Chinese Medicine". www.au.tsinghua.edu.cn. Retrieved 2023-11-07.
  17. ^ US8112230B2, Zhang, Ningbo; Li, Shao & Zhang, Bo, "Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines", issued 2012-02-07 
Retrieved from "https://en.wikipedia.org/w/index.php?title=Draft:Shao_Li&oldid=1231389269"